Jichao Chen

Longmian Avenue, 639
Nanjing, 211198, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Design, synthesis and structure-activity relationship analysis of bufalin as antitumor agents.

Design, synthesis and structure-activity relationship analysis of bufalin as antitumor agents.

Journal: Bioorganic & medicinal chemistry letters

Published: June 09, 2026

Design, synthesis, and anti-inflammatory evaluation of novel analogues derived from the natural product reticuline.

Design, synthesis, and anti-inflammatory evaluation of novel analogues derived from the natural product reticuline.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: June 04, 2026

Recent advances in peptide-drug conjugates as anticancer agents.

Recent advances in peptide-drug conjugates as anticancer agents.

Journal: European journal of medicinal chemistry

Published: October 15, 2025

Tubulin-based dual-target compounds and protein degraders for cancer therapy-An updated review (2021-present).

Tubulin-based dual-target compounds and protein degraders for cancer therapy-An updated review (2021-present).

Journal: European journal of medicinal chemistry

Published: August 05, 2025

An updated review of small-molecule HPK1 kinase inhibitors (2016-present).

An updated review of small-molecule HPK1 kinase inhibitors (2016-present).

Journal: Future medicinal chemistry

Published: November 25, 2024

Insights into direct KRAS inhibition strategies for cancer treatment.

Insights into direct KRAS inhibition strategies for cancer treatment.

Journal: Future medicinal chemistry

Published: November 21, 2024

Palladium-Mediated Bioorthogonal System for Prodrug Activation of N-Benzylbenzamide-Containing Tubulin Polymerization Inhibitors for the Treatment of Solid Tumors.

Palladium-Mediated Bioorthogonal System for Prodrug Activation of N-Benzylbenzamide-Containing Tubulin Polymerization Inhibitors for the Treatment of Solid Tumors.

Journal: Journal of medicinal chemistry

Published: November 01, 2024

Insights into tumor-derived exosome inhibition in cancer therapy.

Insights into tumor-derived exosome inhibition in cancer therapy.

Journal: European journal of medicinal chemistry

Published: October 02, 2024

Novel agents derived from natural product β-elemene: A second round of design and synthesis to enhance antitumor properties.

Novel agents derived from natural product β-elemene: A second round of design and synthesis to enhance antitumor properties.

Journal: Bioorganic & medicinal chemistry

Published: September 20, 2024

Design, synthesis, and biological evaluation of novel HPK1 inhibitors possessing 3-cyano-quinoline moiety.

Design, synthesis, and biological evaluation of novel HPK1 inhibitors possessing 3-cyano-quinoline moiety.

Journal: Bioorganic chemistry

Published: July 18, 2024

Development of natural product-based targeted protein degraders as anticancer agents.

Development of natural product-based targeted protein degraders as anticancer agents.

Journal: Bioorganic chemistry

Published: June 30, 2024

Gold-Catalyzed Double Spirocyclization of 3-Ene-1,7-diyne Esters to Dispiroheterocycles.

Gold-Catalyzed Double Spirocyclization of 3-Ene-1,7-diyne Esters to Dispiroheterocycles.

Journal: Organic letters

Published: April 08, 2024

Showing 1-12 of 22

Last Updated: 09/26/2026